{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:49:56Z","timestamp":1781977796387,"version":"3.54.5"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MC068"],"award-info":[{"award-number":["ZR2021MC068"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MC020"],"award-info":[{"award-number":["ZR2020MC020"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02284-9","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:47:55Z","timestamp":1781970475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macrophages in oncoviral infections: from immune regulators to therapeutic targets"],"prefix":"10.1007","volume":"75","author":[{"given":"Ruixue","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"2284_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207.","journal-title":"Signal Transduct Target Ther"},{"key":"2284_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41586-020-2316-7","volume":"582","author":"Z Bian","year":"2020","unstructured":"Bian Z, Gong Y, Huang T, Lee CZW, Bian L, Bai Z, et al. Deciphering human macrophage development at single-cell resolution. Nature. 2020;582:571\u20136.","journal-title":"Nature"},{"key":"2284_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1189\/jlb.0310153","volume":"88","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Lewis CE. NF-kappaB as a central regulator of macrophage function in tumors. J Leukoc Biol. 2010;88:877\u201384.","journal-title":"J Leukoc Biol"},{"key":"2284_CR4","doi-asserted-by":"publisher","first-page":"352371","DOI":"10.1155\/2014\/352371","volume":"2014","author":"Y Yang","year":"2014","unstructured":"Yang Y, Kim SC, Yu T, Yi YS, Rhee MH, Sung GH, et al. Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm. 2014;2014:352371.","journal-title":"Mediators Inflamm"},{"key":"2284_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00011-021-01442-5","volume":"70","author":"RC Castro","year":"2021","unstructured":"Castro RC, Goncales RA, Zambuzi FA, Frantz FG. Notch signaling pathway in infectious diseases: role in the regulation of immune response. Inflamm Res. 2021;70:261\u201374.","journal-title":"Inflamm Res"},{"key":"2284_CR6","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1128\/JVI.78.14.7667-7676.2004","volume":"78","author":"M Foster-Cuevas","year":"2004","unstructured":"Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol. 2004;78:7667\u201376.","journal-title":"J Virol"},{"key":"2284_CR7","doi-asserted-by":"publisher","first-page":"669566","DOI":"10.3389\/fimmu.2021.669566","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, Li Y, Wu X, Zhang Q, Chen S, Ma X, et al. Ironing out the details: how iron orchestrates macrophage polarization. Front Immunol. 2021;12:669566.","journal-title":"Front Immunol"},{"key":"2284_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s13311-013-0254-x","volume":"11","author":"A Yao","year":"2014","unstructured":"Yao A, Liu F, Chen K, Tang L, Liu L, Zhang K, et al. Programmed death 1 deficiency induces the polarization of macrophages\/microglia to the M1 phenotype after spinal cord injury in mice. Neurotherapeutics. 2014;11:636\u201350.","journal-title":"Neurotherapeutics"},{"key":"2284_CR9","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J Immunol. 2000;164:6166\u201373.","journal-title":"J Immunol"},{"issue":"7","key":"2284_CR10","first-page":"e70547","volume":"2026","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li Y, Cao J, Qiu Y, Yu K, Deng S. The role of macrophages in cancer: from basic research to clinical applications. MedComm. 2020;2026(7):e70547.","journal-title":"MedComm"},{"key":"2284_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 2019;10:1084.","journal-title":"Front Immunol"},{"key":"2284_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-94-007-0782-5_7","volume":"714","author":"I Shabo","year":"2011","unstructured":"Shabo I, Svanvik J. Expression of macrophage antigens by tumor cells. Adv Exp Med Biol. 2011;714:141\u201350.","journal-title":"Adv Exp Med Biol"},{"key":"2284_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.057","author":"Y Wang","year":"2025","unstructured":"Wang Y, Mao J, Wang Y, Wang R, Duan D, Liu Z, et al. Macrophage-induced immunomodulation in oral tissue repair and regeneration: Recent advances and future perspectives. J Adv Res. 2025.S2090-1232(25)00954-3. https:\/\/doi.org\/10.1016\/j.jare.2025.11.057","journal-title":"J Adv Res"},{"issue":"3","key":"2284_CR14","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/rmv.70034","volume":"35","author":"S Mezouar","year":"2025","unstructured":"Mezouar S, Mege JL. Monitoring macrophage polarization in infectious disease, lesson from SARS-CoV\u20102 infection. Rev Med Virol. 2025;35(3):e70034.","journal-title":"Rev Med Virol"},{"key":"2284_CR15","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s12272-016-0820-y","volume":"39","author":"I Rhee","year":"2016","unstructured":"Rhee I. Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res. 2016;39:1588\u201396.","journal-title":"Arch Pharm Res"},{"key":"2284_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ajpath.2014.09.022","volume":"185","author":"H Ohama","year":"2015","unstructured":"Ohama H, Asai A, Ito I, Suzuki S, Kobayashi M, Higuchi K, et al. M2b macrophage elimination and improved resistance of mice with chronic alcohol consumption to opportunistic infections. Am J Pathol. 2015;185:420\u201331.","journal-title":"Am J Pathol"},{"issue":"4","key":"2284_CR17","first-page":"1098","volume":"11","author":"T Carta","year":"2021","unstructured":"Carta T, Razzuoli E, Fruscione F, Zinellu S, Meloni D, Anfossi A, et al. Comparative phenotypic and functional analyses of the effects of IL-10 or TGF-beta on porcine macrophages. Anim (Basel). 2021;11(4):1098.","journal-title":"Anim (Basel)"},{"key":"2284_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.imbio.2017.02.006","volume":"222","author":"EB Lurier","year":"2017","unstructured":"Lurier EB, Dalton D, Dampier W, Raman P, Nassiri S, Ferraro NM, et al. Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing. Immunobiology. 2017;222:847\u201356.","journal-title":"Immunobiology"},{"key":"2284_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","volume":"29","author":"SY Weng","year":"2018","unstructured":"Weng SY, Wang X, Vijayan S, Tang Y, Kim YO, Padberg K, et al. IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal. EBioMedicine. 2018;29:92\u2013103.","journal-title":"EBioMedicine"},{"key":"2284_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.molonc.2007.10.003","volume":"1","author":"EY Lin","year":"2007","unstructured":"Lin EY, Li JF, Bricard G, Wang W, Deng Y, Sellers R, et al. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol. 2007;1:288\u2013302.","journal-title":"Mol Oncol"},{"key":"2284_CR21","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.2147\/OTT.S336548","volume":"14","author":"X Ma","year":"2021","unstructured":"Ma X, Gao Y, Chen Y, Liu J, Yang C, Bao C, et al. M2-type macrophages induce tregs generation by activating the TGF-beta\/smad signalling pathway to promote colorectal cancer development. Onco Targets Ther. 2021;14:5391\u2013402.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"2284_CR22","doi-asserted-by":"publisher","first-page":"qiaf088","DOI":"10.1093\/jleuko\/qiaf088","volume":"117","author":"A Brantly","year":"2025","unstructured":"Brantly A, Yeakle K, Bouchard MJ, Gaskill PJ, Nonnemacher MR. The role of liver macrophages in viral liver pathogenesis. J Leukoc Biol. 2025;117(9):qiaf088.","journal-title":"J Leukoc Biol"},{"key":"2284_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"2284_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/bjc.2011.189","volume":"105","author":"MJ Gooden","year":"2011","unstructured":"Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105:93\u2013103.","journal-title":"Br J Cancer"},{"key":"2284_CR25","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00018-016-2166-5","volume":"73","author":"C Belgiovine","year":"2016","unstructured":"Belgiovine C, D\u2019Incalci M, Allavena P, Frapolli R. Tumor-associated macrophages and anti-tumor therapies: complex links. Cell Mol Life Sci. 2016;73:2411\u201324.","journal-title":"Cell Mol Life Sci"},{"key":"2284_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2407-10-220","volume":"10","author":"F Dai","year":"2010","unstructured":"Dai F, Liu L, Che G, Yu N, Pu Q, Zhang S, et al. The number and microlocalization of tumor-associated immune cells are associated with patient\u2019s survival time in non-small cell lung cancer. BMC Cancer. 2010;10:220.","journal-title":"BMC Cancer"},{"issue":"7","key":"2284_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/cancers10070213","volume":"10","author":"ML Tornesello","year":"2018","unstructured":"Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM. Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers. Cancers (Basel). 2018;10(7):213.","journal-title":"Cancers (Basel)"},{"key":"2284_CR28","doi-asserted-by":"publisher","first-page":"e70121","DOI":"10.1002\/rmv.70121","volume":"36","author":"N Jindal","year":"2026","unstructured":"Jindal N, Mishra BB, Kumar A, Rana S, Pandey K, Chandra Sahoo G. A deep dive into oncogenic viruses understanding their role in cancer and approaches for prevention. Rev Med Virol. 2026;36:e70121.","journal-title":"Rev Med Virol"},{"issue":"7","key":"2284_CR29","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/cancers17071212","volume":"17","author":"M Konstantaraki","year":"2025","unstructured":"Konstantaraki M, Berdiaki A, Neagu M, Zurac S, Krasagakis K, Nikitovic D. Understanding merkel cell carcinoma: pathogenic signaling, extracellular matrix dynamics, and novel treatment approaches. Cancers (Basel). 2025;17(7):1212.","journal-title":"Cancers (Basel)"},{"key":"2284_CR30","doi-asserted-by":"publisher","first-page":"e0232517","DOI":"10.1371\/journal.pone.0232517","volume":"15","author":"MD Mendoza","year":"2020","unstructured":"Mendoza MD, Santonja C, Gonzalez-Vela C, Concha A, Iglesias Pena N, Andres-Esteban EM, et al. The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironment. PLoS ONE. 2020;15:e0232517.","journal-title":"PLoS ONE"},{"key":"2284_CR31","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1016\/j.jid.2022.04.029","volume":"142","author":"T Schlemeyer","year":"2022","unstructured":"Schlemeyer T, Ohnezeit D, Virdi S, Korner C, Weisselberg S, Starzonek S, et al. Merkel cell carcinoma and immune evasion: merkel cell polyomavirus small T-antigen\u2013induced surface changes can be reverted by therapeutic intervention. J Invest Dermatol. 2022;142:3071\u201381. e13.","journal-title":"J Invest Dermatol"},{"key":"2284_CR32","first-page":"7610","volume":"7","author":"DS Behr","year":"2014","unstructured":"Behr DS, Peitsch WK, Hametner C, Lasitschka F, Houben R, Schonhaar K, et al. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas. Int J Clin Exp Pathol. 2014;7:7610\u201321.","journal-title":"Int J Clin Exp Pathol"},{"key":"2284_CR33","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1111\/exd.70030","volume":"34","author":"DL Drum","year":"2025","unstructured":"Drum DL, Jallorina AG, Wan LS, Chang VT, Lee-Wong MF. Non-genetic biomarkers in merkel cell carcinoma: prognostic implications and predictive utility for response to anti-PD-(L)1 immune checkpoint inhibitors. Exp Dermatol. 2025;34:e70030.","journal-title":"Exp Dermatol"},{"key":"2284_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cancers6021047","volume":"6","author":"R Wheat","year":"2014","unstructured":"Wheat R, Roberts C, Waterboer T, Steele J, Marsden J, Steven NM, et al. Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel). 2014;6:1047\u201364.","journal-title":"Cancers (Basel)"},{"key":"2284_CR35","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1158\/1078-0432.CCR-21-3408","volume":"28","author":"B Zhang","year":"2022","unstructured":"Zhang B, Choi IK. Facts and hopes in the relationship of EBV with cancer immunity and immunotherapy. Clin Cancer Res. 2022;28:4363\u20139.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2284_CR36","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.3390\/cancers16244169","volume":"16","author":"A De Moyano","year":"2024","unstructured":"Moyano A, Colado A, Amarillo ME, De Matteo E, Preciado MV, Borge M, et al. Epstein barr virus (EBV) latent membrane protein 1 (LMP-1) regulates functional markers in intermediate and non-classical monocytes. Cancers (Basel). 2024;16(24):4169.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2284_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/cancers17091433","volume":"17","author":"MN Alibrahim","year":"2025","unstructured":"Alibrahim MN, Gloghini A, Carbone A. Immune deficiency\/dysregulation-associated EBV-positive classic hodgkin lymphoma. Cancers (Basel). 2025;17(9):1433.","journal-title":"Cancers (Basel)"},{"key":"2284_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s007050050492","volume":"144","author":"M Shimakage","year":"1999","unstructured":"Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G, et al. Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol. 1999;144:157\u201366.","journal-title":"Arch Virol"},{"key":"2284_CR39","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2017-07-794529","volume":"131","author":"H Higuchi","year":"2018","unstructured":"Higuchi H, Yamakawa N, Imadome KI, Yahata T, Kotaki R, Ogata J, et al. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma. Blood. 2018;131:2552\u201367.","journal-title":"Blood"},{"issue":"3","key":"2284_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/cancers17030491","volume":"17","author":"S Srisathaporn","year":"2025","unstructured":"Srisathaporn S, Ekalaksananan T, Heawchaiyaphum C, Aromseree S, Maranon DG, Altina NH, et al. EBV-Induced LINC00944: a driver of oral cancer progression and influencer of macrophage differentiation. Cancers (Basel). 2025;17(3):491.","journal-title":"Cancers (Basel)"},{"key":"2284_CR41","doi-asserted-by":"publisher","first-page":"e1011934","DOI":"10.1371\/journal.ppat.1011934","volume":"20","author":"X Xu","year":"2024","unstructured":"Xu X, Zhu N, Zheng J, Peng Y, Zeng MS, Deng K, et al. EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation. PLoS Pathog. 2024;20:e1011934.","journal-title":"PLoS Pathog"},{"key":"2284_CR42","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1038\/s41467-025-64037-2","volume":"16","author":"ZL Hu","year":"2025","unstructured":"Hu ZL, Li ZQ, Wang Y, Luo YL, Guo WP, Meng N, et al. Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion. Nat Commun. 2025;16:9015.","journal-title":"Nat Commun"},{"key":"2284_CR43","doi-asserted-by":"publisher","first-page":"105279","DOI":"10.1016\/j.oraloncology.2021.105279","volume":"117","author":"A Burassakarn","year":"2021","unstructured":"Burassakarn A, Srisathaporn S, Pientong C, Wongjampa W, Vatanasapt P, Patarapadungkit N, et al. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I\/IL-6\/TNF-alpha pathway. Oral Oncol. 2021;117:105279.","journal-title":"Oral Oncol"},{"key":"2284_CR44","doi-asserted-by":"publisher","first-page":"24291","DOI":"10.18632\/oncotarget.4552","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Duan Y, Cheng S, Chen Y, Hu Y, Zhang L, et al. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma. Oncotarget. 2015;6:24291\u2013303.","journal-title":"Oncotarget"},{"key":"2284_CR45","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.7150\/thno.100171","volume":"14","author":"T Xiang","year":"2024","unstructured":"Xiang T, Sun F, Liu T, Zhao J, Yang J, Ouyang D, et al. EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment. Theranostics. 2024;14:5123\u201340.","journal-title":"Theranostics"},{"issue":"6","key":"2284_CR46","doi-asserted-by":"publisher","first-page":"e008375","DOI":"10.1136\/jitc-2023-008375","volume":"12","author":"Y Chen","year":"2024","unstructured":"Chen Y, Ouyang D, Wang Y, Pan Q, Zhao J, Chen H, et al. EBV promotes TCR-T-cell therapy resistance by inducing CD163\u2009+\u2009M2 macrophage polarization and MMP9 secretion. J Immunother Cancer. 2024;12(6):e008375.","journal-title":"J Immunother Cancer"},{"key":"2284_CR47","doi-asserted-by":"publisher","first-page":"113117","DOI":"10.1016\/j.isci.2025.113117","volume":"28","author":"J Arai","year":"2025","unstructured":"Arai J, Hayakawa Y, Suzuki N, Kinoshita H, Hata M, Kurokawa K, et al. ARID1A mutation drives gastric tumorigenesis via activating type 2 immune dominant microenvironment. iScience. 2025;28:113117.","journal-title":"iScience"},{"key":"2284_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/path.6036","volume":"259","author":"WC Tang","year":"2023","unstructured":"Tang WC, Tsao SW, Jones GE, Liu X, Tsai MH, Delecluse HJ, et al. Latent membrane protein 1 and macrophage-derived TNFalpha synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinoma. J Pathol. 2023;259:163\u201379.","journal-title":"J Pathol"},{"key":"2284_CR49","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","volume":"9","author":"KF Rabe","year":"2021","unstructured":"Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021;9:1288\u201398.","journal-title":"Lancet Respir Med"},{"key":"2284_CR50","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jamadermatol.2023.0627","volume":"159","author":"AS Paller","year":"2023","unstructured":"Paller AS, Flohr C, Cork M, Bewley A, Blauvelt A, Hong HC, et al. Efficacy and safety of tralokinumab in adolescents with moderate to severe atopic dermatitis: the phase 3 ECZTRA 6 randomized clinical trial. JAMA Dermatol. 2023;159:596\u2013605.","journal-title":"JAMA Dermatol"},{"key":"2284_CR51","doi-asserted-by":"publisher","first-page":"114797","DOI":"10.1016\/j.biopha.2023.114797","volume":"163","author":"H He","year":"2023","unstructured":"He H, Lei F, Huang L, Wang K, Yang Y, Chen L, et al. Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350\/CD89-targeted bispecific antibody. Biomed Pharmacother. 2023;163:114797.","journal-title":"Biomed Pharmacother"},{"key":"2284_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-023-00137-z","volume":"4","author":"A Qin","year":"2023","unstructured":"Qin A, Wang XJ, Fu J, Shen A, Huang X, Chen Z, et al. hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS\/NLRP3 signaling pathway. Mol Biomed. 2023;4:27.","journal-title":"Mol Biomed"},{"key":"2284_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40659-025-00597-3","volume":"58","author":"P Chen","year":"2025","unstructured":"Chen P, Chen Z, Sui W, Han W. Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review. Biol Res. 2025;58:16.","journal-title":"Biol Res"},{"key":"2284_CR54","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/annonc\/mdz197","volume":"30","author":"F Wang","year":"2019","unstructured":"Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai GH, et al. Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib\/II clinical trial NCT02915432. Ann Oncol. 2019;30:1479\u201386.","journal-title":"Ann Oncol"},{"key":"2284_CR55","doi-asserted-by":"publisher","first-page":"110286","DOI":"10.1016\/j.virol.2024.110286","volume":"601","author":"S Neumeyer","year":"2025","unstructured":"Neumeyer S, Tagawa T. The Kaposi sarcoma herpesvirus control of monocytes, macrophages, and the tumour microenvironment. Virology. 2025;601:110286.","journal-title":"Virology"},{"key":"2284_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2217\/fmb.10.105","volume":"5","author":"HR Lee","year":"2010","unstructured":"Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. Immune evasion by Kaposi\u2019s sarcoma-associated herpesvirus. Future Microbiol. 2010;5:1349\u201365.","journal-title":"Future Microbiol"},{"key":"2284_CR57","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.chembiol.2024.10.003","volume":"31","author":"H Miura","year":"2024","unstructured":"Miura H, Wang KH, Inagaki T, Chuang F, Shimoda M, Izumiya C, et al. A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell death. Cell Chem Biol. 2024;31:1909\u201325. e7.","journal-title":"Cell Chem Biol"},{"key":"2284_CR58","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/JVI.02786-13","volume":"88","author":"N Sharma-Walia","year":"2014","unstructured":"Sharma-Walia N, Chandran K, Patel K, Veettil MV, Marginean A. The Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis. J Virol. 2014;88:2131\u201356.","journal-title":"J Virol"},{"key":"2284_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41416-020-0872-0","volume":"123","author":"MS Gilardini Montani","year":"2020","unstructured":"Gilardini Montani MS, Falcinelli L, Santarelli R, Granato M, Romeo MA, Cecere N, et al. KSHV infection skews macrophage polarisation towards M2-like\/TAM and activates Ire1 alpha-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression. Br J Cancer. 2020;123:298\u2013306.","journal-title":"Br J Cancer"},{"key":"2284_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1189\/jlb.0409251","volume":"87","author":"Z Qin","year":"2010","unstructured":"Qin Z, Kearney P, Plaisance K, Parsons CH. Pivotal advance: Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol. 2010;87:25\u201334.","journal-title":"J Leukoc Biol"},{"key":"2284_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.imlet.2008.06.011","volume":"120","author":"M Cirone","year":"2008","unstructured":"Cirone M, Lucania G, Aleandri S, Borgia G, Trivedi P, Cuomo L, et al. Suppression of dendritic cell differentiation through cytokines released by primary effusion lymphoma cells. Immunol Lett. 2008;120:37\u201341.","journal-title":"Immunol Lett"},{"key":"2284_CR62","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871.420k25_2871_2879","volume":"94","author":"KD Jones","year":"1999","unstructured":"Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and Viral IL-6 in the spontaneous growth of kaposi\u2019s sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999;94:2871\u20139.","journal-title":"Blood"},{"key":"2284_CR63","doi-asserted-by":"publisher","first-page":"105560","DOI":"10.1016\/j.biocel.2019.06.008","volume":"114","author":"MS Gilardini Montani","year":"2019","unstructured":"Gilardini Montani MS, Falcinelli L, Santarelli R, Romeo MA, Granato M, Faggioni A, et al. Kaposi Sarcoma Herpes Virus (KSHV) infection inhibits macrophage formation and survival by counteracting macrophage colony-stimulating factor (M-CSF)-induced increase of reactive oxygen species (ROS), c-Jun N-terminal kinase (JNK) phosphorylation and autophagy. Int J Biochem Cell Biol. 2019;114:105560.","journal-title":"Int J Biochem Cell Biol"},{"key":"2284_CR64","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jcp.21722","volume":"219","author":"C Salata","year":"2009","unstructured":"Salata C, Curtarello M, Calistri A, Sartori E, Sette P, de Bernard M, et al. vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity. J Cell Physiol. 2009;219:698\u2013706.","journal-title":"J Cell Physiol"},{"key":"2284_CR65","doi-asserted-by":"publisher","first-page":"e1011703","DOI":"10.1371\/journal.ppat.1011703","volume":"19","author":"M Shimoda","year":"2023","unstructured":"Shimoda M, Inagaki T, Davis RR, Merleev A, Tepper CG, Maverakis E, et al. Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages. PLoS Pathog. 2023;19:e1011703.","journal-title":"PLoS Pathog"},{"key":"2284_CR66","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1128\/JVI.00841-14","volume":"88","author":"KA Bussey","year":"2014","unstructured":"Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, et al. The gammaherpesviruses Kaposi\u2019s sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. J Virol. 2014;88:9245\u201359.","journal-title":"J Virol"},{"key":"2284_CR67","doi-asserted-by":"publisher","first-page":"104825","DOI":"10.1016\/j.antiviral.2020.104825","volume":"180","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang H, Chen X. Pemetrexed inhibits Kaposi\u2019s sarcoma-associated herpesvirus replication through blocking dTMP synthesis. Antiviral Res. 2020;180:104825.","journal-title":"Antiviral Res"},{"key":"2284_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1061186X.2022.2104299","volume":"31","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang Y, Lin Z, Wu X, Fan W, Chen J. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review. J Drug Target. 2023;31:1\u201313.","journal-title":"J Drug Target"},{"key":"2284_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165\u2013166","author":"R Pandit","year":"2020","unstructured":"Pandit R, Chen L, Gotz J. The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev. 2020;165\u2013166:1\u201314.","journal-title":"Adv Drug Deliv Rev"},{"key":"2284_CR70","doi-asserted-by":"publisher","first-page":"124208","DOI":"10.1016\/j.ijbiomac.2023.124208","volume":"239","author":"H Wang","year":"2023","unstructured":"Wang H, Shao W, Lu X, Gao C, Fang L, Yang X, et al. Synthesis, characterization, and in vitro anti-tumor activity studies of the hyaluronic acid-mangiferin-methotrexate nanodrug targeted delivery system. Int J Biol Macromol. 2023;239:124208.","journal-title":"Int J Biol Macromol"},{"key":"2284_CR71","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1166\/jnn.2018.15218","volume":"18","author":"ZP Ye","year":"2018","unstructured":"Ye ZP, Ai XL, Faramand AM, Fang F. Macrophages as nanocarriers for drug delivery: novel therapeutics for central nervous system diseases. J Nanosci Nanotechnol. 2018;18:471\u201385.","journal-title":"J Nanosci Nanotechnol"},{"key":"2284_CR72","doi-asserted-by":"publisher","first-page":"e70298","DOI":"10.1002\/jmv.70298","volume":"97","author":"L Yao","year":"2025","unstructured":"Yao L, Zhang Q, Gao X, Li F, Zhang L, Zhang J, et al. Macrophage-mediated delivery of miR-34a-5p-nanoparticles for pathogenic inhibition of kaposi\u2019s sarcoma-associated herpesvirus. J Med Virol. 2025;97:e70298.","journal-title":"J Med Virol"},{"issue":"23","key":"2284_CR73","doi-asserted-by":"publisher","first-page":"12946","DOI":"10.3390\/ijms252312946","volume":"25","author":"C Liu","year":"2024","unstructured":"Liu C, Yin X, Xu H, Xu J, Gong M, Li Z, et al. Microneedle-array-mediated transdermal delivery of GCV-functionalized zeolitic imidazolate framework-8 nanoparticles for KSHV treatment. Int J Mol Sci. 2024;25(23):12946.","journal-title":"Int J Mol Sci"},{"key":"2284_CR74","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s12672-025-03772-w","volume":"16","author":"H Tan","year":"2025","unstructured":"Tan H, Yao L, Zhang R, Ye M, Shi S, Zhang J, et al. Macrophage-mediated delivery of ganciclovir nanocomplexes inhibits the pathogenicity of Kaposi\u2019s sarcoma-associated herpesvirus. Discov Oncol. 2025;16:1943.","journal-title":"Discov Oncol"},{"key":"2284_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","volume":"61","author":"A Boltjes","year":"2014","unstructured":"Boltjes A, Movita D, Boonstra A, Woltman AM. The role of Kupffer cells in hepatitis B and hepatitis C virus infections. J Hepatol. 2014;61:660\u201371.","journal-title":"J Hepatol"},{"key":"2284_CR76","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26461","volume":"233","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Zou W, Du J, Zhao Y. The origins and homeostasis of monocytes and tissue-resident macrophages in physiological situation. J Cell Physiol. 2018;233:6425\u201339.","journal-title":"J Cell Physiol"},{"key":"2284_CR77","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306\u201321.","journal-title":"Nat Rev Immunol"},{"key":"2284_CR78","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300\u201312.","journal-title":"J Hepatol"},{"key":"2284_CR79","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.jhepr.2025.101547","volume":"7","author":"B Bueloni","year":"2025","unstructured":"Bueloni B, Fiore E, Cantero MJ, Lameroli L, Atorrasagasti C, Ciarlantini M, et al. RAC1 as a novel therapeutic target for acute liver failure. JHEP Rep. 2025;7:101547.","journal-title":"JHEP Rep"},{"key":"2284_CR80","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00109-023-02405-5","volume":"102","author":"M Tian","year":"2024","unstructured":"Tian M, Wu N, Xie X, Liu T, You Y, Ma S, et al. Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury. J Mol Med (Berl). 2024;102:257\u201372.","journal-title":"J Mol Med (Berl)"},{"issue":"587","key":"2284_CR81","doi-asserted-by":"publisher","first-page":"eaba6322","DOI":"10.1126\/scitranslmed.aba6322","volume":"13","author":"A Nishio","year":"2021","unstructured":"Nishio A, Bolte FJ, Takeda K, Park N, Yu ZX, Park H, et al. Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection. Sci Transl Med. 2021;13(587):eaba6322.","journal-title":"Sci Transl Med"},{"key":"2284_CR82","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/liv.12806","volume":"35","author":"G Sitia","year":"2015","unstructured":"Sitia G. Towards personalized medicine in chronic HBV patients? Liver Int. 2015;35:1783\u20135.","journal-title":"Liver Int"},{"key":"2284_CR83","doi-asserted-by":"publisher","first-page":"424","DOI":"10.14218\/JCTH.2020.00046","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Li S, Duan X, Yang C, Xu M, Chen L. Macrophage phenotypes and hepatitis B virus infection. J Clin Transl Hepatol. 2020;8:424\u201331.","journal-title":"J Clin Transl Hepatol"},{"key":"2284_CR84","doi-asserted-by":"publisher","first-page":"19917","DOI":"10.1038\/s41598-024-70924-3","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu J, Yu L, Zeng R, Pan W. The hijacking of HBV by small extracellular vesicles inhibits M1 macrophages to facilitate immune evasion. Sci Rep. 2024;14:19917.","journal-title":"Sci Rep"},{"key":"2284_CR85","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/hep.30897","volume":"71","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhao X, Wang Z, Shu W, Li L, Li Y, et al. Nuclear sensor interferon-inducible protein 16 inhibits the function of hepatitis B virus covalently closed circular DNA by integrating innate immune activation and epigenetic suppression. Hepatology. 2020;71:1154\u201369.","journal-title":"Hepatology"},{"key":"2284_CR86","doi-asserted-by":"publisher","first-page":"152810","DOI":"10.1016\/j.imbio.2024.152810","volume":"229","author":"Q Zong","year":"2024","unstructured":"Zong Q, Zhang H, Liu F, Li J, Liu Q, Duan Z, et al. Activation of the cGAS-STING pathway by viral dsDNA leading to M1 polarization of macrophages mediates antiviral activity against hepatitis B virus. Immunobiology. 2024;229:152810.","journal-title":"Immunobiology"},{"key":"2284_CR87","doi-asserted-by":"publisher","first-page":"110284","DOI":"10.1016\/j.celrep.2021.110284","volume":"38","author":"Y Li","year":"2022","unstructured":"Li Y, Zhu Y, Feng S, Ishida Y, Chiu TP, Saito T, et al. Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1beta to downregulate PPARalpha and FOXO3. Cell Rep. 2022;38:110284.","journal-title":"Cell Rep"},{"key":"2284_CR88","doi-asserted-by":"publisher","first-page":"e1012079","DOI":"10.1371\/journal.ppat.1012079","volume":"20","author":"Y Li","year":"2024","unstructured":"Li Y, Wu C, Lee J, Ning Q, Lim J, Eoh H, et al. Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages. PLoS Pathog. 2024;20:e1012079.","journal-title":"PLoS Pathog"},{"key":"2284_CR89","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/jmcb\/mjz104","volume":"12","author":"X Zhao","year":"2020","unstructured":"Zhao X, Sun L, Mu T, Yi J, Ma C, Xie H, et al. An HBV-encoded miRNA activates innate immunity to restrict HBV replication. J Mol Cell Biol. 2020;12:263\u201376.","journal-title":"J Mol Cell Biol"},{"key":"2284_CR90","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jmii.2025.07.001","volume":"59","author":"HJ Liao","year":"2026","unstructured":"Liao HJ, Cheng LP, Hsieh YC, Wu CS, Yang HC, Chyuan IT, et al. Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistence. J Microbiol Immunol Infect. 2026;59:172\u201380.","journal-title":"J Microbiol Immunol Infect"},{"key":"2284_CR91","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.4049\/jimmunol.1700540","volume":"200","author":"J Liu","year":"2018","unstructured":"Liu J, Yu Q, Wu W, Huang X, Broering R, Werner M, et al. TLR2 stimulation strengthens intrahepatic myeloid-derived cell-mediated T cell tolerance through inducing kupffer cell expansion and IL-10 production. J Immunol. 2018;200:2341\u201351.","journal-title":"J Immunol"},{"key":"2284_CR92","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.4049\/jimmunol.2100618","volume":"208","author":"Y Liu","year":"2022","unstructured":"Liu Y, Qin L, Wang J, Xie X, Zhang Y, Li C, et al. miR-146a maintains immune tolerance of kupffer cells and facilitates hepatitis B virus persistence in mice. J Immunol. 2022;208:2558\u201372.","journal-title":"J Immunol"},{"key":"2284_CR93","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00018-018-2753-8","volume":"75","author":"W Wang","year":"2018","unstructured":"Wang W, Bian H, Li F, Li X, Zhang D, Sun S, et al. HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines. Cell Mol Life Sci. 2018;75:2627\u201341.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2284_CR94","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/mmr.2023.12950","volume":"27","author":"L Sun","year":"2023","unstructured":"Sun L, Yu J, Zhang N, Wang Y, Qi J. M1 macrophages may be effective adjuvants for promoting Th\u201317 differentiation in HBeAg positive hepatitis patients with ALT =2ULN. Mol Med Rep. 2023;27(3):63.","journal-title":"Mol Med Rep"},{"key":"2284_CR95","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jvh.13809","volume":"30","author":"Y Fei","year":"2023","unstructured":"Fei Y, Wang Z, Huang M, Wu X, Hu F, Zhu J, et al. MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma. J Viral Hepat. 2023;30:417\u201326.","journal-title":"J Viral Hepat"},{"key":"2284_CR96","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/14787210.2023.2225771","volume":"21","author":"C Forbes","year":"2023","unstructured":"Forbes C, Lavoie L, Satram S, Shen L, Thanawala V, Arizpe A, et al. Global importance of new treatment strategies to efforts to control hepatitis B virus. Expert Rev Anti Infect Ther. 2023;21:847\u201362.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2284_CR97","doi-asserted-by":"publisher","first-page":"112219","DOI":"10.1016\/j.intimp.2024.112219","volume":"134","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li J, Zong Q, Duan Z, Liu F, Duan W, et al. Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis. Int Immunopharmacol. 2024;134:112219.","journal-title":"Int Immunopharmacol"},{"key":"2284_CR98","doi-asserted-by":"publisher","first-page":"1421195","DOI":"10.3389\/fcimb.2024.1421195","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, Yin Q, Xu S, Tan X, Liang Y, Chen C, et al. IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p\/PCGF3\/PI3K\/AKT signaling axis. Front Cell Infect Microbiol. 2024;14:1421195.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"2284_CR99","doi-asserted-by":"publisher","first-page":"e29627","DOI":"10.1002\/jmv.29627","volume":"96","author":"L Wu","year":"2024","unstructured":"Wu L, Deng H, Feng X, Xie D, Li Z, Chen J, et al. Interferon-gamma(+) Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization. J Med Virol 2024;96(5):e29627.","journal-title":"J Med Virol"},{"key":"2284_CR100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13020-024-00888-z","volume":"19","author":"Z Wu","year":"2024","unstructured":"Wu Z, Zhao X, Li R, Wen X, Xiu Y, Long M, et al. The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages. Chin Med. 2024;19:48.","journal-title":"Chin Med"},{"key":"2284_CR101","doi-asserted-by":"publisher","first-page":"199316","DOI":"10.1016\/j.virusres.2024.199316","volume":"341","author":"R Xu","year":"2024","unstructured":"Xu R, Wu Y, Xiang X, Lv X, He M, Xu C, et al. Sulforaphane effectively inhibits HBV by altering Treg\/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo. Virus Res. 2024;341:199316.","journal-title":"Virus Res"},{"key":"2284_CR102","doi-asserted-by":"publisher","first-page":"868616","DOI":"10.3389\/fimmu.2022.868616","volume":"13","author":"Z Meng","year":"2022","unstructured":"Meng Z, Liu J, Kosinska AD, Lu M. Editorial: targeting the immune system to treat hepatitis B virus infection. Front Immunol. 2022;13:868616.","journal-title":"Front Immunol"},{"key":"2284_CR103","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1084\/jem.20182124","volume":"216","author":"A Etzerodt","year":"2019","unstructured":"Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, et al. Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression. J Exp Med. 2019;216:2394\u2013411.","journal-title":"J Exp Med"},{"key":"2284_CR104","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/ijms.3.47","volume":"3","author":"SL Chen","year":"2006","unstructured":"Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47\u201352.","journal-title":"Int J Med Sci"},{"key":"2284_CR105","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1128\/JVI.00996-08","volume":"83","author":"M Heydtmann","year":"2009","unstructured":"Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol. 2009;83:2796\u2013802.","journal-title":"J Virol"},{"key":"2284_CR106","doi-asserted-by":"publisher","first-page":"e29282","DOI":"10.5812\/hepatmon.29282","volume":"15","author":"Y Wang","year":"2015","unstructured":"Wang Y, Li J, Wang X, Zhou Y, Zhang T, Ho W. HCV dsRNA-activated macrophages inhibit HCV replication in hepatocytes. Hepat Mon. 2015;15:e29282.","journal-title":"Hepat Mon"},{"key":"2284_CR107","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s10620-018-5401-0","volume":"64","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang W, Zou Z, Hu Z, Fan Q, Xiong J. Hepatitis C virus entry into macrophages\/monocytes mainly depends on the phagocytosis of macrophages. Dig Dis Sci. 2019;64:1226\u201337.","journal-title":"Dig Dis Sci"},{"key":"2284_CR108","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1074\/jbc.R700024200","volume":"283","author":"T von Hahn","year":"2008","unstructured":"von Hahn T, Rice CM. Hepatitis C virus entry. J Biol Chem. 2008;283:3689\u201393.","journal-title":"J Biol Chem"},{"key":"2284_CR109","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3892\/etm.2022.11448","volume":"24","author":"S Zhao","year":"2022","unstructured":"Zhao S, Si M, Deng X, Wang D, Kong L, Zhang Q. HCV inhibits M2a, M2b and M2c macrophage polarization via HCV core protein engagement with Toll-like receptor 2. Exp Ther Med. 2022;24:522.","journal-title":"Exp Ther Med"},{"key":"2284_CR110","doi-asserted-by":"publisher","first-page":"36160","DOI":"10.1038\/srep36160","volume":"6","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Wang Y, Zhai N, Song H, Li H, Yang Y, et al. HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway. Sci Rep. 2016;6:36160.","journal-title":"Sci Rep"},{"key":"2284_CR111","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/j.gastro.2009.09.009","volume":"138","author":"Z Tu","year":"2010","unstructured":"Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS. Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells. Gastroenterology. 2010;138:305\u201314.","journal-title":"Gastroenterology"},{"key":"2284_CR112","doi-asserted-by":"publisher","first-page":"109631","DOI":"10.1016\/j.intimp.2022.109631","volume":"117","author":"R Tao","year":"2023","unstructured":"Tao R, Han M, Yuan W, Xiao F, Huang J, Wang X, et al. Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis. Int Immunopharmacol. 2023;117:109631.","journal-title":"Int Immunopharmacol"},{"key":"2284_CR113","doi-asserted-by":"publisher","first-page":"654998","DOI":"10.3389\/fimmu.2021.654998","volume":"12","author":"X Song","year":"2021","unstructured":"Song X, Gao X, Wang Y, Raja R, Zhang Y, Yang S, et al. HCV core protein induces chemokine CCL2 and CXCL10 expression through NF-kappaB signaling pathway in macrophages. Front Immunol. 2021;12:654998.","journal-title":"Front Immunol"},{"key":"2284_CR114","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1099\/jmm.0.001185","volume":"69","author":"C Fan","year":"2020","unstructured":"Fan C, Zhang X, Zhang P, Zhao J, Shen H, Zhang Y, et al. LPS stimulation during HCV infection induces MMP\/TIMP1 imbalance in macrophages. J Med Microbiol. 2020;69:759\u201366.","journal-title":"J Med Microbiol"},{"key":"2284_CR115","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/00365521.2018.1481996","volume":"53","author":"T Lund Laursen","year":"2018","unstructured":"Lund Laursen T, Brockner Siggard C, Kazankov K, Damgaard Sandahl T, Moller HJ, Ong A, et al. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology. Scand J Gastroenterol. 2018;53:986\u201393.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"2284_CR116","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/jcm10020221","volume":"10","author":"PS Sung","year":"2021","unstructured":"Sung PS, Shin EC. Immunological mechanisms for hepatocellular carcinoma risk after direct-acting antiviral treatment of hepatitis C virus infection. J Clin Med. 2021;10(2):221.","journal-title":"J Clin Med"},{"key":"2284_CR117","doi-asserted-by":"crossref","unstructured":"Millian DE, Arroyave E, Wanninger TG, Krishnan S, Bao D, Zhang JR et al. Alterations in the hepatic microenvironment following direct-acting antiviral therapy for chronic hepatitis C. medRxiv. 2025.","DOI":"10.1101\/2025.02.17.25321289"},{"key":"2284_CR118","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.gastro.2017.10.035","volume":"154","author":"JD Debes","year":"2018","unstructured":"Debes JD, van Tilborg M, Groothuismink ZMA, Hansen BE, Schulze Zur Wiesch J, von Felden J, et al. Levels of cytokines in serum associate with development of hepatocellular carcinoma in patients with HCV infection treated with direct-acting antivirals. Gastroenterology. 2018;154:515\u20137. e3.","journal-title":"Gastroenterology"},{"key":"2284_CR119","doi-asserted-by":"publisher","first-page":"e28950","DOI":"10.1002\/jmv.28950","volume":"95","author":"X Gong","year":"2023","unstructured":"Gong X, Chi H, Xia Z, Yang G, Tian G. Advances in HPV-associated tumor management: therapeutic strategies and emerging insights. J Med Virol. 2023;95:e28950.","journal-title":"J Med Virol"},{"key":"2284_CR120","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cas.13476","volume":"109","author":"A Kawachi","year":"2018","unstructured":"Kawachi A, Yoshida H, Kitano S, Ino Y, Kato T, Hiraoka N. Tumor-associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma. Cancer Sci. 2018;109:863\u201370.","journal-title":"Cancer Sci"},{"key":"2284_CR121","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.4049\/jimmunol.0904104","volume":"185","author":"Q Cheng","year":"2010","unstructured":"Cheng Q, McKeown SJ, Santos L, Santiago FS, Khachigian LM, Morand EF, et al. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol. 2010;185:1238\u201347.","journal-title":"J Immunol"},{"key":"2284_CR122","doi-asserted-by":"publisher","first-page":"e28410","DOI":"10.1002\/jmv.28410","volume":"95","author":"S Wang","year":"2023","unstructured":"Wang S, Li X, Liu C, Yuan Y, Ma F. Single-cell transcriptomic analysis of the role of HPV16-positive macrophages in cervical cancer prognosis. J Med Virol. 2023;95:e28410.","journal-title":"J Med Virol"},{"key":"2284_CR123","doi-asserted-by":"publisher","first-page":"1586806","DOI":"10.3389\/fimmu.2025.1586806","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhao B. The role of tumor-associated macrophages in HPV induced cervical cancer. Front Immunol. 2025;16:1586806.","journal-title":"Front Immunol"},{"issue":"8","key":"2284_CR124","doi-asserted-by":"publisher","first-page":"e011915","DOI":"10.1136\/jitc-2025-011915","volume":"13","author":"R Prins","year":"2025","unstructured":"Prins R, Fernandez DJ, Akbari O, Da Silva DM, Kast WM. HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages. J Immunother Cancer. 2025;13(8):e011915.","journal-title":"J Immunother Cancer"},{"key":"2284_CR125","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000487434","volume":"83","author":"L Li","year":"2018","unstructured":"Li L, Yu S, Zang C. Low necroptosis process predicts poor treatment outcome of human papillomavirus positive cervical cancers by decreasing tumor-associated macrophages M1 polarization. Gynecol Obstet Invest. 2018;83:259\u201367.","journal-title":"Gynecol Obstet Invest"},{"key":"2284_CR126","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.celrep.2016.05.032","volume":"15","author":"D Legarda","year":"2016","unstructured":"Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, et al. CYLD proteolysis protects macrophages from TNF-mediated auto-necroptosis induced by LPS and licensed by type I IFN. Cell Rep. 2016;15:2449\u201361.","journal-title":"Cell Rep"},{"key":"2284_CR127","doi-asserted-by":"publisher","first-page":"23725","DOI":"10.1038\/s41598-024-74399-0","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Liu Y, Luo X, Pan T, Zhang T, Hu L, et al. HPV16 E6-induced M2 macrophage polarization in the cervical microenvironment via exosomal miR-204-5p. Sci Rep. 2024;14:23725.","journal-title":"Sci Rep"},{"key":"2284_CR128","doi-asserted-by":"publisher","first-page":"156831","DOI":"10.1016\/j.cyto.2024.156831","volume":"186","author":"J Yadav","year":"2025","unstructured":"Yadav J, Tripathi T, Chaudhary A, Janjua D, Joshi U, Aggarwal N, et al. Influence of head and neck cancer exosomes on macrophage polarization. Cytokine. 2025;186:156831.","journal-title":"Cytokine"},{"issue":"12","key":"2284_CR129","doi-asserted-by":"publisher","first-page":"e007670","DOI":"10.1136\/jitc-2023-007670","volume":"11","author":"J Wu","year":"2023","unstructured":"Wu J, Pang X, Yang X, Zhang M, Chen B, Fan H et al. M1 macrophages induce PD-L1(hi) cell-led collective invasion in HPV-positive head and neck squamous cell carcinoma via TNF-alpha\/CDK4\/UPS14. J Immunother Cancer 2023;11(12):e007670.","journal-title":"J Immunother Cancer"},{"key":"2284_CR130","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/cas.15281","volume":"113","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang S, Tong F, Wang Y, Wei L. HPV(+) HNSCC-derived exosomal miR-9-5p inhibits TGF-beta signaling-mediated fibroblast phenotypic transformation through NOX4. Cancer Sci. 2022;113:1475\u201387.","journal-title":"Cancer Sci"},{"key":"2284_CR131","doi-asserted-by":"publisher","first-page":"1693487","DOI":"10.3389\/fonc.2025.1693487","volume":"15","author":"H Liu","year":"2025","unstructured":"Liu H, Zhang S, Liu Z, Gong T, Duan S, Liu T, et al. M1 macrophage-derived exosomal miR-20b promotes radiosensitization via CCND1 in HPV(+) HNSCC. Front Oncol. 2025;15:1693487.","journal-title":"Front Oncol"},{"key":"2284_CR132","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3892\/or.2020.7628","volume":"44","author":"E Fu","year":"2020","unstructured":"Fu E, Liu T, Yu S, Chen X, Song L, Lou H, et al. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB\u2013EGF. Oncol Rep. 2020;44:698\u2013710.","journal-title":"Oncol Rep"},{"key":"2284_CR133","doi-asserted-by":"publisher","first-page":"1380448","DOI":"10.3389\/fonc.2024.1380448","volume":"14","author":"M Liang","year":"2024","unstructured":"Liang M, Sheng L, Ke Y, Wu Z. The research progress on radiation resistance of cervical cancer. Front Oncol. 2024;14:1380448.","journal-title":"Front Oncol"},{"key":"2284_CR134","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10147-020-01666-1","volume":"25","author":"H Sato","year":"2020","unstructured":"Sato H, Okonogi N, Nakano T. Rationale of combination of anti-PD-1\/PD-L1 antibody therapy and radiotherapy for cancer treatment. Int J Clin Oncol. 2020;25:801\u20139.","journal-title":"Int J Clin Oncol"},{"key":"2284_CR135","doi-asserted-by":"publisher","first-page":"e70305","DOI":"10.1002\/ctm2.70305","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qiu K, Ai J, Xu M, Wang B, Alu A, et al. Ad-E6\/7-HR vaccine improves the prophylactic and therapeutic efficacy in HPV-associated cancers. Clin Transl Med. 2025;15:e70305.","journal-title":"Clin Transl Med"},{"issue":"9","key":"2284_CR136","doi-asserted-by":"publisher","first-page":"e012090","DOI":"10.1136\/jitc-2025-012090","volume":"13","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Cao B, Li L, Zhou Y, Ni C, Zhao Y, et al. mRNA-encoded mutant HPV16\/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice. J Immunother Cancer. 2025;13(9):e012090.","journal-title":"J Immunother Cancer"},{"key":"2284_CR137","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s00262-020-02651-3","volume":"69","author":"Y Che","year":"2020","unstructured":"Che Y, Yang Y, Suo J, An Y, Wang X. Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer. Cancer Immunol Immunother. 2020;69:2651\u201364.","journal-title":"Cancer Immunol Immunother"},{"key":"2284_CR138","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13577-025-01246-3","volume":"38","author":"Q Tang","year":"2025","unstructured":"Tang Q, Yang Y, Sun J. EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical cancer. Hum Cell. 2025;38:119.","journal-title":"Hum Cell"},{"key":"2284_CR139","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12967-024-06036-3","volume":"23","author":"K Chen","year":"2025","unstructured":"Chen K, Li X, Dong S, Guo Y, Luo Z, Zhuang SM, et al. Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC. J Transl Med. 2025;23:27.","journal-title":"J Transl Med"},{"issue":"9","key":"2284_CR140","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers11091400","volume":"11","author":"NY Sun","year":"2019","unstructured":"Sun NY, Chen YL, Wu WY, Lin HW, Chiang YC, Chang CF, et al. Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization. Cancers (Basel). 2019;11(9):1400.","journal-title":"Cancers (Basel)"},{"key":"2284_CR141","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00262-018-2130-3","volume":"67","author":"S Mukherjee","year":"2018","unstructured":"Mukherjee S, Hussaini R, White R, Atwi D, Fried A, Sampat S, et al. TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors. Cancer Immunol Immunother. 2018;67:761\u201374.","journal-title":"Cancer Immunol Immunother"},{"key":"2284_CR142","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2014.03.025","volume":"104","author":"HT Fuzii","year":"2014","unstructured":"Fuzii HT, da Silva Dias GA, de Barros RJ, Falcao LF, Quaresma JA. Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Life Sci. 2014;104:9\u201314.","journal-title":"Life Sci"},{"key":"2284_CR143","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.virusres.2017.01.016","volume":"232","author":"J Wang","year":"2017","unstructured":"Wang J, Yang S, Liu L, Wang H, Yang B. HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity. Virus Res. 2017;232:13\u201321.","journal-title":"Virus Res"},{"key":"2284_CR144","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.4049\/jimmunol.1700111","volume":"199","author":"J Wang","year":"2017","unstructured":"Wang J, Kang L, Song D, Liu L, Yang S, Ma L, et al. Ku70 senses HTLV-1 DNA and modulates HTLV-1 replication. J Immunol. 2017;199:2475\u201382.","journal-title":"J Immunol"},{"key":"2284_CR145","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12977-021-00550-8","volume":"18","author":"DO Pinto","year":"2021","unstructured":"Pinto DO, Al Sharif S, Mensah G, Cowen M, Khatkar P, Erickson J, et al. Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread. Retrovirology. 2021;18:6.","journal-title":"Retrovirology"},{"key":"2284_CR146","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood.V95.1.30","volume":"95","author":"H Hasegawa","year":"2000","unstructured":"Hasegawa H, Nomura T, Kohno M, Tateishi N, Suzuki Y, Maeda N, et al. Increased chemokine receptor CCR7\/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood. 2000;95:30\u20138.","journal-title":"Blood"},{"issue":"4","key":"2284_CR147","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/v17040471","volume":"17","author":"R Moles","year":"2025","unstructured":"Moles R, Omsland M, Pise-Masison CA, Subleski JJ, McVicar DW, Sarkis S, et al. HTLV-1 p13 protein hijacks macrophage polarization and promotes T-Cell recruitment. Viruses. 2025;17(4):471.","journal-title":"Viruses"},{"key":"2284_CR148","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12865-024-00670-8","volume":"26","author":"S de Souza","year":"2025","unstructured":"de Souza S, Melo GA, Caloba C, Campos MCS, Pimenta JV, Dutra FF, et al. HTLV-1-infected cells drive the differentiation of monocytes into macrophages in vitro. BMC Immunol. 2025;26:24.","journal-title":"BMC Immunol"},{"key":"2284_CR149","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/1040841X.2025.2461045","volume":"51","author":"C Das","year":"2025","unstructured":"Das C, Kundu CN. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects. Crit Rev Microbiol. 2025;51:991\u20131014.","journal-title":"Crit Rev Microbiol"},{"key":"2284_CR150","doi-asserted-by":"publisher","first-page":"27150","DOI":"10.1038\/srep27150","volume":"6","author":"K Sugata","year":"2016","unstructured":"Sugata K, Yasunaga J, Miura M, Akari H, Utsunomiya A, Nosaka K, et al. Enhancement of anti-STLV-1\/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep. 2016;6:27150.","journal-title":"Sci Rep"},{"key":"2284_CR151","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s13365-020-00832-5","volume":"26","author":"HR Bidkhori","year":"2020","unstructured":"Bidkhori HR, Hedayati-Moghaddam MR, Mosavat A, Valizadeh N, Tadayon M, Ahmadi Ghezeldasht S, et al. The IL-18, IL-12, and IFN-gamma expression in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients, HTLV-1 carriers, and healthy subjects. J Neurovirol. 2020;26:338\u201346.","journal-title":"J Neurovirol"},{"key":"2284_CR152","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-9-16","volume":"9","author":"Y Enose-Akahata","year":"2012","unstructured":"Enose-Akahata Y, Matsuura E, Tanaka Y, Oh U, Jacobson S. Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease. Retrovirology. 2012;9:16.","journal-title":"Retrovirology"},{"key":"2284_CR153","doi-asserted-by":"publisher","first-page":"1776431","DOI":"10.3389\/fimmu.2026.1776431","volume":"17","author":"J Wu","year":"2026","unstructured":"Wu J, Hu C, Yang G. Identification of CCND1 and IL7R as core JAK-STAT pathway genes promoting hepatitis B-related liver fibrosis. Front Immunol. 2026;17:1776431.","journal-title":"Front Immunol"},{"key":"2284_CR154","doi-asserted-by":"publisher","first-page":"e0175625","DOI":"10.1128\/jvi.01756-25","volume":"100","author":"Q Wu","year":"2026","unstructured":"Wu Q, Xu Q, Liu J, Zhao T. Roles of the cGAS-STING signaling pathway in viral latency. J Virol. 2026;100:e0175625.","journal-title":"J Virol"},{"key":"2284_CR155","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, et al. The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. 2020;80:106210.","journal-title":"Int Immunopharmacol"},{"key":"2284_CR156","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13045-021-01214-y","volume":"14","author":"N Awasthi","year":"2021","unstructured":"Awasthi N, Liongue C, Ward AC. STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer. J Hematol Oncol. 2021;14:198.","journal-title":"J Hematol Oncol"},{"key":"2284_CR157","doi-asserted-by":"publisher","first-page":"217772","DOI":"10.1016\/j.canlet.2025.217772","volume":"625","author":"X Bai","year":"2025","unstructured":"Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ, Zhang JK, et al. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025;625:217772.","journal-title":"Cancer Lett"},{"key":"2284_CR158","doi-asserted-by":"publisher","first-page":"e0164123","DOI":"10.1128\/spectrum.01641-23","volume":"11","author":"D Yang","year":"2023","unstructured":"Yang D, Tian R, Deng R, Xue B, Liu S, Wang L, et al. The dual functions of KDM7A in HBV replication and immune microenvironment. Microbiol Spectr. 2023;11:e0164123.","journal-title":"Microbiol Spectr"},{"key":"2284_CR159","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"2284_CR160","doi-asserted-by":"publisher","first-page":"780839","DOI":"10.3389\/fimmu.2022.780839","volume":"13","author":"T Gauthier","year":"2022","unstructured":"Gauthier T, Chen W. Modulation of macrophage immunometabolism: a new approach to fight infections. Front Immunol. 2022;13:780839.","journal-title":"Front Immunol"},{"key":"2284_CR161","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cmet.2022.02.011","volume":"34","author":"K Kudo","year":"2022","unstructured":"Kudo K, Miki Y, Carreras J, Nakayama S, Nakamoto Y, Ito M, et al. Secreted phospholipase A(2) modifies extracellular vesicles and accelerates B cell lymphoma. Cell Metab. 2022;34:615\u2013e6338.","journal-title":"Cell Metab"},{"key":"2284_CR162","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/vim.2021.0101","volume":"35","author":"LT Jennelle","year":"2022","unstructured":"Jennelle LT, Magoro T, Angelucci AR, Dandekar A, Hahn YS. Hepatitis C virus alters macrophage cholesterol metabolism through interaction with scavenger receptors. Viral Immunol. 2022;35:223\u201335.","journal-title":"Viral Immunol"},{"key":"2284_CR163","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3389\/fimmu.2018.01650","volume":"9","author":"A Vidyarthi","year":"2018","unstructured":"Vidyarthi A, Khan N, Agnihotri T, Negi S, Das DK, Aqdas M, et al. TLR-3 stimulation skews M2 macrophages to M1 through IFN-alphabeta signaling and restricts tumor progression. Front Immunol. 2018;9:1650.","journal-title":"Front Immunol"},{"key":"2284_CR164","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1021\/acs.biomac.8b00239","volume":"19","author":"L Liu","year":"2018","unstructured":"Liu L, He H, Liang R, Yi H, Meng X, Chen Z, et al. ROS-inducing micelles sensitize tumor-associated macrophages to TLR3 stimulation for potent immunotherapy. Biomacromolecules. 2018;19:2146\u201355.","journal-title":"Biomacromolecules"},{"key":"2284_CR165","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1021\/acs.jmedchem.4c00508","volume":"67","author":"Q Lv","year":"2024","unstructured":"Lv Q, Yang H, Wang D, Zhou H, Wang J, Zhang Y, et al. Discovery of a novel CSF-1R inhibitor with highly improved pharmacokinetic profiles and superior efficacy in colorectal cancer immunotherapy. J Med Chem. 2024;67:6854\u201379.","journal-title":"J Med Chem"},{"key":"2284_CR166","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Guan Z, Dai X, Shen Y, Wei Q, Ren L, et al. Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer. Nat Commun. 2021;12:4310.","journal-title":"Nat Commun"},{"key":"2284_CR167","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"2284_CR168","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40:274\u201388.","journal-title":"Immunity"},{"issue":"1","key":"2284_CR169","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00011-026-02196-8","volume":"75","author":"L Chen","year":"2026","unstructured":"Chen L, Hong C, Xie Y. The characterization of RUNX1-mediated macrophage polarization requires a multidimensional perspective beyond the M1\/M2 binary. Inflamm Res. 2026;75(1):49.","journal-title":"Inflamm Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02284-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:02:27Z","timestamp":1781974947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02284-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02284-9","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"151"}}